# Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

> **NCT07380711** · — · RECRUITING · sponsor: **Sanofi** · enrollment: 500 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07380711
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2030-08-14
- **Final completion:** 2030-08-14
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07380711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07380711, "Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07380711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*